Leukemia, myelogenous, chronic, bcr-abl positive Clinical Trials

Delta Trials tracks 12 clinical trials for Leukemia, myelogenous, chronic, bcr-abl positive in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 9 trials have reached completion. This research is carried out at 141 clinical sites around the world. An additional 2 trials have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.